EP1553936A2 - Zusammensetzung für die behandlung und rehydratisierung zur reduzierung der nebenwirkungen bei gastroenteritis beim erwachsenen - Google Patents

Zusammensetzung für die behandlung und rehydratisierung zur reduzierung der nebenwirkungen bei gastroenteritis beim erwachsenen

Info

Publication number
EP1553936A2
EP1553936A2 EP03767923A EP03767923A EP1553936A2 EP 1553936 A2 EP1553936 A2 EP 1553936A2 EP 03767923 A EP03767923 A EP 03767923A EP 03767923 A EP03767923 A EP 03767923A EP 1553936 A2 EP1553936 A2 EP 1553936A2
Authority
EP
European Patent Office
Prior art keywords
treatment
composition
milliequivalents
glucose
sucrose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03767923A
Other languages
English (en)
French (fr)
Inventor
Jack Auzerie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ellipse Pharmaceuticals SAS
Original Assignee
Ellipse Pharmaceuticals SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellipse Pharmaceuticals SAS filed Critical Ellipse Pharmaceuticals SAS
Publication of EP1553936A2 publication Critical patent/EP1553936A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP03767923A 2002-10-09 2003-10-09 Zusammensetzung für die behandlung und rehydratisierung zur reduzierung der nebenwirkungen bei gastroenteritis beim erwachsenen Withdrawn EP1553936A2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0212544 2002-10-09
FR0212544A FR2845600B1 (fr) 2002-10-09 2002-10-09 Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte
PCT/FR2003/050083 WO2004032823A2 (fr) 2002-10-09 2003-10-09 Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte

Publications (1)

Publication Number Publication Date
EP1553936A2 true EP1553936A2 (de) 2005-07-20

Family

ID=32039576

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03767923A Withdrawn EP1553936A2 (de) 2002-10-09 2003-10-09 Zusammensetzung für die behandlung und rehydratisierung zur reduzierung der nebenwirkungen bei gastroenteritis beim erwachsenen

Country Status (4)

Country Link
EP (1) EP1553936A2 (de)
AU (1) AU2003292354A1 (de)
FR (1) FR2845600B1 (de)
WO (1) WO2004032823A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2446797C1 (ru) * 2011-02-24 2012-04-10 Петр Леонидович Щербаков Способ лечения кислотозависимых состояний, ассоциированных с хеликобактер пилори
ITRM20120341A1 (it) 2012-07-17 2014-01-18 Er La Salute Della Donna E Del Bambino Soluzione glucosalina di mantenimento per la somministrazione parenterale ad uso pediatrico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558061B1 (fr) * 1983-12-27 1986-08-08 Auzerie Jack Composition pour solutions de rehydratation par voie orale des nourrissons et solutions la contenant
GB8512345D0 (en) * 1985-05-15 1985-06-19 Scras Anti-diarrhea compositions
GB8908361D0 (en) * 1989-04-13 1989-06-01 Beecham Group Plc Composition
JP2711759B2 (ja) * 1990-10-24 1998-02-10 エスエス製薬 株式会社 止瀉剤組成物
FR2770778B1 (fr) * 1997-11-12 2000-05-26 Investigations Therapeutiques Composition pour le traitement des gastro-enterites aigues, procede de fabrication de cette composition et solution de traitement obtenue a partir de cette composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004032823A2 *

Also Published As

Publication number Publication date
FR2845600B1 (fr) 2005-07-08
WO2004032823A2 (fr) 2004-04-22
AU2003292354A1 (en) 2004-05-04
AU2003292354A8 (en) 2004-05-04
WO2004032823A8 (fr) 2005-05-06
WO2004032823A3 (fr) 2004-12-23
FR2845600A1 (fr) 2004-04-16

Similar Documents

Publication Publication Date Title
US7993682B2 (en) Electrolyte purgative
JP2013146281A (ja) 栄養補助食品
FR2815227A1 (fr) Composition anti-stress destinee a etre incorporee principalement a des vehicules nutritionnels
US20060040003A1 (en) Dietary supplement for supressing appetite, enhancing and extending satiety, improving glycemic control, and stimulant free
JP2010162040A (ja) 栄養補助食品及び消化器系関連障害の治療方法
EP1349556A2 (de) Zusammensetzung aus aktivkohle und verfahren zum verringern der katersymptome assoziiert mit dem verbrauch von alkoholischen getränken
Hemat Principles of orthomolecularism
US5145678A (en) Method of reducing blood serum cholesterol
WO2008152265A1 (fr) Utilisation de solutions ioniques isoosmotiques a base d'eau de mer pour la fabrication de dispositifs medicaux pour la prevention des complications du rhume courant ou du syndrome grippal
KR20060113339A (ko) 당 및 당알콜을 함유하는 변비개선용 조성물
JP2004520413A (ja) 血中コレステロール低下能と心血関係疾患の予防及び治療能を有する組成物
Quah et al. Prospective randomized crossover trial comparing fibre with lactulose in the treatment of idiopathic chronic constipation
BE1023090B1 (fr) Composition
WO2004032823A2 (fr) Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte
FR2687548A1 (fr) Nouvelle composition dietetique hypocalorique.
JP5584411B2 (ja) ホモシステイン低下用組成物
FR2922109A1 (fr) Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre.
BE1026122B1 (fr) Composition pour prévenir ou réduire les effets d'une intoxication alcoolique
McKone et al. Adrenal insufficiency and testicular failure secondary to megestrol acetate therapy in a patient with cystic fibrosis
BE1011385A3 (fr) Utilisation d'un agent chimique pour diminuer les variations du tour de taille et l'effet de constipation lie a la prise d'autres agents.
US20090062231A1 (en) Appetite Suppressant Composition and Method of Appetite Suppression
EP0919239A1 (de) Pharmazeutische Zusammensetzung zur Behandlung von akuter Gastroenteritis, welche ein Rehydrations-Lösung sowie eine Verbindung mit synergistischer Wirkung enthält
JP3380287B2 (ja) 血中アルコール濃度上昇阻害飲料
WO2024083827A1 (fr) Combinaison de psyllium, baobab et acacia pour la prevention et le traitement de la constipation ou des troubles du transit
FR3140754A1 (fr) Produit de combinaison pour la prévention et le traitement de la constipation ou des troubles du transit

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050506

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20091007

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100218